key: cord-0929353-zthn143c
authors: Price, James Richard; Mookerjee, Siddharth; Dyakova, Eleonora; Myall, Ashleigh; Leung, Wendy; Weiße, Andrea Yeong; Shersing, Yeeshika; Brannigan, Eimear Therese; Galletly, Tracey; Muir, David; Randell, Paul; Davies, Frances; Bolt, Frances; Barahona, Mauricio; Otter, Jonathan Ashley; Holmes, Alison H
title: Development and delivery of a real-time hospital-onset COVID-19 surveillance system using network analysis
date: 2020-07-08
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa892
sha: 3e48951d95022ea4ce81a5b42ce6cb41724ff2c9
doc_id: 929353
cord_uid: zthn143c

BACKGROUND: Understanding nosocomial acquisition, outbreaks and transmission chains in real-time will be fundamental to ensuring infection prevention measures are effective in controlling COVID-19 in healthcare. We report the design and implementation of a hospital-onset COVID-19 infection (HOCI) surveillance system for an acute healthcare setting to target prevention interventions. METHODS: The study took place in a large teaching hospital group in London, UK. All patients tested for SARS-CoV-2 between 4(th) March and 14(th) April 2020 were included. Utilising data routinely collected through electronic healthcare systems we developed a novel surveillance system for determining and reporting HOCI incidence and providing real-time network analysis. We provided daily reports on incidence and trends over time to support HOCI investigation, and generated geo-temporal reports using network analysis to interrogate admission pathways for common epidemiological links to infer transmission chains. By working with stakeholders the reports were co-designed for end users. RESULTS: Real-time surveillance reports revealed: changing rates of HOCI throughout the course of the COVID-19 epidemic; key wards fuelling probable transmission events; HOCIs over-represented in particular specialities managing high-risk patients; the importance of integrating analysis of individual prior pathways; and the value of co-design in producing data visualisation. Our surveillance system can effectively support national surveillance. CONCLUSIONS: Through early analysis of the novel surveillance system we have provided a description of HOCI rates and trends over time using real-time shifting denominator data. We demonstrate the importance of including the analysis of patient pathways and networks in characterising risk of transmission and targeting infection control interventions.

Within five months of its recognition, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally causing 6.8 million reported cases of coronavirus disease 2019 (COVID-19) [1] . Dramatic differences in country-specific mortality rates (0.5 -84 per 100,000) are reported [2] and the WHO estimate 397K (5.8%) have died of COVID-19 globally [1] . Mortality rates in hospitalised patients exceed 26%, with higher rates observed in persons over 65 years old [3, 4] . Worryingly, COVID-19-associated hospital admissions continue to increase causing unparalleled clinical and economic challenges to healthcare settings worldwide.

Nosocomial SARS-CoV-2 acquisition has been reported [5, 6] yet our understanding of transmission dynamics is imperfect. Extensive and sustained community transmission, presymptomatic transmission and likely long tail of infection suggest unique transmission potential compared to other respiratory pathogens [7, 8] . Furthermore, transmission risk is amplified by over-stretched healthcare capacity, lack of isolation facilities, complex patient pathways, fluctuating supplies of personal protective equipment, and use of aerosolgenerating procedures [9] . It is plausible that uncontrolled nosocomial transmissions will challenge pandemic control and fuel peaks of infection. Unsurprisingly healthcare worker anxiety around healthcare-acquired COVID-19 infection is sizeable [10] .

Understanding healthcare acquisition and transmission chains will be critical for any recovery strategy. The challenges of capturing dynamic and complex individual patient pathways and establishing a pragmatic case definition for surveillance must be addressed. Furthermore, the number of COVID-19-susceptible inpatients will vary within and between healthcare institutes and will depend upon the stage of the epidemic.

A c c e p t e d M a n u s c r i p t International bodies have introduced surveillance programmes to monitor trends in incidence, prevalence, rates of hospitalisation and deaths associated with COVID-19 [11, 12] . Recently the UK government mandated surveillance of COVID-19 infections identified in hospitals [13] . Whilst these data are likely to provide valuable insights into national epidemiological trends the absence of ward-level data will limit impact on local infection prevent and control (IPC) interventions. To address this, surveillance incorporating factors such as the clinical setting and patient pathways is essential.

We designed and implemented a pragmatic, real-time surveillance system for hospital-onset COVID-19 infection (HOCI) within our acute healthcare institute prior to the UK government mandate. We present the early analysis of the data generated, based on mapping patient pathways and transmission networks, including the identification of healthcare transmission, and accounting for epidemiological trends in COVID-19 infection.

Furthermore, we highlight how these systems can be effectively integrated into national surveillance systems.

A c c e p t e d M a n u s c r i p t

The surveillance system was developed and utilised at a large London teaching hospital group serving a diverse population, comprising five hospitals across four sites. Our institute has 1,200 inpatient beds, employs 12,000 staff and undertakes 1.2 million episodes of patient contact per year. 

Any patient-admission tested for SARS-CoV-2 with their first positive sample  7 days after admission to hospital was included. Patients were tested for SARS-CoV-2 based on national recommendations, which at the time of writing were any patients requiring admission to hospital with clinical or radiological evidence of pneumonia or acute respiratory distress syndrome or an influenza-like illness [14] . All patients were tested using throat and nasal or nasopharyngeal swabs. Diagnosis was made using commercially available real-time PCR assays.

Daily incidence rate was assessed by determining patient-admissions with and without COVID-19 positive tests.

A c c e p t e d M a n u s c r i p t Because the incubation period for COVID-19 is <14 days [7] it is plausible that development of symptoms within 14 days of hospital admission could be attributed to communityacquisition. With a median time to symptoms of 5 days [7] , we made the pragmatic assumption that symptom development < 7 days was likely to reflect community-acquisition, and day 7-13 more likely reflected healthcare-acquisition. Consequently, we developed two definitions: HOCI was defined as any patient with a SARS-CoV-2 positive test sample ≥ 14 days after admission and did not have any symptoms of COVID-19 (fever, shortness of breath, cough, malaise) on admission. Possible HOCI (pHOCI) was defined as any patient with a SARS-CoV-2 positive sample 7 days but <14days after admission and did not have symptoms of COVID-19 on admission as determined by review of electronic patient records.

Since our development of HOCI classifications, UK government has provided specific definitions based on timing between healthcare admission and positive test [13] . The definitions we developed parallel these but include patient-level information, which may provide higher-resolution case identification.

HOCI clusters were defined as two or more cases of HOCI or pHOCI occurring on the same ward within 14 days of each other.

Details are found in Appendix 1. This system was developed with input from end-users (infection prevention and control teams) and clinical leads. To provide clear and useable outputs, unique data and visual reports were developed. Data outputs included daily patientadmissions rates, daily new confirmed cases of COVID-19, daily incidence of HOCI, and cumulative HOCI cases over time and space.

A c c e p t e d M a n u s c r i p t

Electronic health records were interrogated to produce visual reports of inpatient pathways by incorporating into a network analysis. The network analysis utilises directed patient ward movements within the preceding 14 days (or up to 14 days in cases of pHOCI) from positive COVID-19 results to establish two key inputs: (i) cumulative number of days spent on individual wards, and (ii) number of incoming and outgoing ward transfers. These inputs were used to create a graphical representation of wards as network nodes, sized to reflect cumulative days spent on the ward and number of HOCI and pHOCI cases. Nodes are connected by arrows, or directed edges, with a width reflecting the cumulative number of movements from one node to another, and their direction. Together, these networks visualised patient flows associated with HOCI and pHOCI, and highlighted epidemiological links within patient pathways.

A c c e p t e d M a n u s c r i p t

Here we report on the early implementation and outputs of our HOCI surveillance system.

Of 907 confirmed COVID-19 positive patient-admissions during the analysis period, 90 (9.9%) met our criteria for HOCI across 39 wards; 28 were positive 7 to <14 days after admission (pHOCI) and 62 were positive ≥14 days after admission (HOCI). The median number of daily cases was 1 (IQR 0-3). By including patient-level data we excluded 15 cases where patients had symptoms of COVID-19 on admission.

Structured reports of daily incidence were generated and distributed to IPC teams and management boards on a daily basis. Three key metrics on SARS-CoV-2 positive patientadmissions were reported: (i) numbers and locations of new cases identified in the preceding 24 hours; (ii) daily incidence trends; and (iii) identification of cases meeting HOCI criteria.

Daily reports highlighted a reduction in hospital inpatient admissions coupled with a proportional rise in COVID-19-positive inpatients ( Figure 1A) . Strikingly, the proportion of HOCI cases remained low. Evaluation of the daily incidence of HOCI ( Figure 1B) 

To support IPC responses, daily reports were augmented with ward-level data and two visual representations were created:

A c c e p t e d M a n u s c r i p t

Prospective data integration allowed real-time HOCI identification. Figure 1C provides an example of a geo-temporal chart generated for individual wards which can be assessed for clusters. Our cluster definition was met 19 times across 19 different wards (involving 70/90 (78%) HOCI and pHOCI cases), including ward areas managing patients at higher risk of complications (renal and haematology).

Where clusters were identified, patient pathways were analysed to assess for epidemiological links. The largest cluster (Ward 14 in Figure 1C ) consisted of 13 HOCI cases identified on a single medical ward (at times managing COVID-19 positive patients in side rooms and cohort bays) over 23 days. Figure 2A provides the patient pathway report for this cluster and reveals that whilst Ward 14 was the common location where the positive result was identified, many cases shared links to other clinical areas. 7/13 (54%) patients spent time on Ward 30, another medical ward, prior to COVID-19 identification. Furthermore, other medical areas (including Ward 3) were common to several patient admission pathways and, whilst most patients were admitted to these areas after the positive results, this may reflect broader pathway involvement.

To further assess common epidemiological links all HOCI cases were incorporated into a network analysis. Figure 3A provides an overview of networks within hospital sites, revealing a complete network of all patient movements prior to the identification of HOCI cases structured by hospital site. The network comprises 49 nodes and 69 edges representing directed transfers. The total patient days spent on each ward varied from <1 to 123 days, and A c c e p t e d M a n u s c r i p t directed numbers of ward transfers ranged from 0 to 6. Three single points of transfers between sites were observed.

At Hospital 1, 10 ward areas were identified. The largest node (Ward 38 in Figure 3A) represents a renal ward that is highly connected, in terms of patient ingress, to two other renal ward (Ward 28 and Ward 37 in Figure 3A ). These wards collectively had 8 HOCIs; 6 on Ward 38 and 1 each on Ward 28 and 37. This suggests dynamics within specialty areas, possibly relating to accessing haemodialysis facilities.

At Hospital 2, 21 ward areas were identified in network analysis ( Figure 3A) . Wide variations of patient days on wards were observed across these ward areas. The largest node (Ward 14 in Figure 3A ) was highly connected to two nodes (Ward 30 and Ward 3 in Figure   3A ). Wards 14, 30 and 3 are surgical wards located within Hospital 2 that were being used as medical wards during the analytical period, including managing patients with COVID-19 in side rooms or cohort bays. In addition to the 13 HOCI identified on Ward 14, an additional 7

HOCIs were identified on highly connected Ward 30 (n=3) and Ward 3 (n=3); representing 22% of 90 HOCIs identified. In turn, this suggested that IPC interventions were required across all of these medical wards, and consolidates findings from the geo-temporal cluster analysis ( Figure 1C and 2) . The analysis highlights that Ward 14 was highly connected with another medical ward (Ward 30), as revealed in Figure 2 and 3A. Although overlaying patient pathways (Figure 2) and mapping these to a network offer complementary information of exposure to prior clinical areas where transmissions could have taken place, this sub-analysis in Figure 3B does not uncover the connectivity of Ward 3 (as seen in Figure 3A ).

Following the analysis period, the UK government mandated institutes to report HOCI on a weekly basis. In response, outputs from our established surveillance system were directly linked to national surveillance system databases, permitting rapid and seamless uploads. This was combined with established infrastructure to support the rapid identification of HOCI clusters, and epidemiological investigation of individual HOCIs with rapid cluster analysis.

A c c e p t e d M a n u s c r i p t

We have developed and implemented a surveillance system that applies network analysis to inform on possible hospital-acquisition and guide IPC interventions. From initial surveillance data analysis we have:

 provided a description of HOCI rates and trends throughout the COVID-19 epidemic curve using real-time shifting denominator data. We have shown that HOCI and pHOCI cases were more common during the early phase of the epidemic curve, prior to the peak. Monitoring epidemiological trends in real-time provides awareness of the institution's trajectory within the pandemic which, in turn, supports future planning,  highlighted key wards common to patient pathways prior to developing HOCI which may represent hubs of transmission, likely owing to frequency of movement through the wards, time spent on them, and patient movements to these wards,  demonstrated the importance of including patient pathway network analysis,  shown that linkage to national surveillance systems is seamless.

Healthcare-associated infections are frequently defined as development of disease >48hours after admission (used for MRSA and Gram-negative blood stream infection and Clostridioides difficile). Due to the prolonged incubation period application of this to HOCI is unsuitable. In March 2020 we developed a clinically-relevant definition. We proposed that development of infection >14 days after admission reflects healthcare-acquisition, whilst infection identified within the incubation period is less certain. Based on the current literature, infections presenting between 7-14 days after admission are more likely to be healthcare-associated than community, which was reflected in our definition. Recently UK government announced the introduction of a national surveillance system, providing epidemiological definitions of hospital-onset infections [13] . Whilst these pragmatic A c c e p t e d M a n u s c r i p t definitions are likely to be valuable in national surveillance, the absence of patient-level data mean that it is plausible that there will be over-reporting of cases.

At the time of writing, no official figures have been published on healthcare-acquired COVID-19, and low-quality data coupled with heterogenous definitions across clinical settings mean our understanding of HOCI rates are imprecise. HOCI rates at our institute have varied considerably depending on the epidemic stage . Figure 1B reveals that rates were positively skewed towards the increase in the epidemic curve when physical distancing and visitor restrictions had not yet been nationally recommended nor implemented locally. The impact of these measures on the epidemiology of this disease remains unclear but this association gives reason to speculate that they may have, at least in part, had an impact.

Surveillance systems are widely used to prospectively monitor nosocomial infection trends and provide early warning signals for outbreaks. These systems commonly reflect static ward areas of known patient populations. Adapting these to COVID-19 has required flexibility to unique and changing circumstances. They must address the rapidly shifting nature of inpatients and case mixes alongside mapping major patient pathway changes, whilst also encompassing complexities of case definitions, the challenge of appropriate denominator data, and diagnostic testing capacity.

Traditionally, surveillance systems identify the ward area (or preceding ward area), where the sample was taken, as the geographical target where IPC activity should focus. Yet due to long incubation periods and pre-symptomatic infection, involvement of the patient pathway for up to 14 days prior to the positive test need to be considered. Network analyses have been previously employed to understand infectious disease transmission and dynamics [15] . To A c c e p t e d M a n u s c r i p t assess geo-temporal associations of individuals and HOCI clusters we employed network analysis at a local hospital level. Mapping patient pathways to networks reveals clinical areas common to HOCI patients pathways , offering evidence of exposure. We found wards in key specialities over-represented in the HOCI and pHOCI case numbers suggesting a need to analyse patient pathway routes across hospital sites and potentially focus IPC interventions on wards earlier in the patient pathway. Furthermore, we found that while network subanalyses identifies common pathways, the exclusion of patients who test positive on a different ward but share pathways underestimates additional key ward exposures. This suggests that evaluation of entire networks, rather than sub-analyses, is likely to provide the most valuable data to inform IPC interventions.

Our work has a number of limitations. First, we used the date of the first positive sample to reflect the date of infection and have not included preceding SARS-CoV-2 negative samples.

It is possible we have over-estimated the incidence of HOCI. Second, disease prevalence will affect the positive predictive value (PPV) of the assay; as COVID-19 prevalence decreases, the PPV will decrease, which in turn can lead to higher false-positive rates. Third, healthcare worker samples were not included, so inferences about the role of staff in HOCI are not available. Fourth, it is possible that secondary COVID-19 infections could occur in patients who have already been diagnosed with COVID-19. Our data do not account for these. Fifth, healthcare exposure within the 14 days prior to admission, which may contribute towards nosocomial acquisition, was not included. Sixth, routine testing for SARS-CoV-2 at discharge is not performed at our institution. Seventh, we screened electronic record of patients to determine symptoms on admission. Although this method is fast, it could have resulted in over-inclusion of patients. Yet, using this method we were able to rule out 15 patients who were symptomatic on admission. Eighth, whilst network analysis incorporates A c c e p t e d M a n u s c r i p t patient-admission journeys the risk of transmission on wards is not inferred. Furthermore, in response to increasing rates many wards changed to COVID-19 cohorting wards at short notice which was challenging to disentangle.

Sharing surveillance strategies for adoption by local, national and international healthcare groups is essential. We developed a customisable surveillance system using platforms that are globally available and can be integrated with other clinical data platforms and national surveillance systems. Further work, incorporating healthcare worker sampling is required to understand the role of staff in HOCI. It is likely that the higher resolution offered by wholegenome sequencing will be required to answer this [16] .

In conclusion, we present the adoption of a network-analysis surveillance system to prospectively identify and characterise COVID-19 infections in hospitalised patients. We identified varying rates of HOCIs associated with epidemiological changes observed through the stages of the pandemic. Through network analysis we revealed that examining entire patient pathways is fundamental to understand common epidemiological links in cases which, in turn, help target IPC activities. As we move into the recovery phase of the pandemic more COVID-naïve patients will be admitted to hospital. Whilst the opportunity to target hospital interventions maybe limited at the height of the pandemic these options will be more achievable in the recovery phase and the importance of appropriate triage of patients along pathways will increase. Preventing transmission and acquisition is going to be fundamental for an effective recovery and robust surveillance systems will be key to achieving this. 

World Health Organisation. Coronavirus disease (COVID-19)

European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 24

A weekly summary of U.S. COVID-19 Hospitalization Data: Laboratory-confirmed COVID-19-associated Hospitalizations (COVID-NET)

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit

Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. The European respiratory

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Covid-19: Doctors sound alarm over hospital transmissions

European Centre for Disease Prevention and Control

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 -COVID-NET, 14 States

Interim data collection -hospital-onset COVID-19. Publication Approval Reference 001559

Modelling the transmission of healthcare associated infections: a systematic review

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

We wish to acknowledge the dedication and support of the Infection Prevention and Control 

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t